Differential expression of protease-activated receptor 2 in a bile duct ligation-induced rat model of liver fibrosis.
- VernacularTitle:蛋白酶活化受体2在大鼠胆汁淤积性肝纤维化肝组织中的表达及其意义
- Author:
Ying-chun LIU
1
;
Xiao-hong GU
;
Yun-dong ZHANG
;
Lan-bo CHEN
;
Hou-mei TANG
Author Information
- Publication Type:Journal Article
- MeSH: Animals; Collagen Type I; metabolism; Collagen Type III; metabolism; Disease Models, Animal; Liver; metabolism; pathology; Liver Cirrhosis, Biliary; metabolism; pathology; Male; Rats; Rats, Sprague-Dawley; Receptor, PAR-2; metabolism
- From: Chinese Journal of Hepatology 2013;21(5):363-366
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo observe the dynamic change in expression of protease-activated receptor 2 (PAR2) during onset and progression of liver fibrosis by using a rat model.
METHODSA cholestatic liver fibrosis model was established in Sprague-Dawley rats (aged 8-9 weeks, body weight 350 - 400 g) by bile duct ligation surgery. Rats receiving a sham operation and unoperated rats served as the negative and normal control groups, respectively. At baseline (pre-surgery) and post-surgery weeks 2, 4, 6, and 8, five rats from each group were sacrificed for whole liver resection. The protein and mRNA expressions of PAR2 and collagen I/III were detected by western blotting and RT-PCR, respectively. Between-group differences were assessed by analysis of variance testing.
RESULTSAt post-surgery week 2, the liver fibrosis group showed higher expression of PAR2 mRNA and protein than either control group. The expression levels of PAR2 continued to rise over time in the liver fibrosis group (peaking at week 8), and were significantly higher than those detected in the control groups (weeks 4-6: P less than 0.05; week 8, P less than 0.05). A similar trend was observed for the expression of collagen I/III.
CONCLUSIONDynamic expression of PAR2 observed in a cholestatic liver fibrosis rat model may indicate a role for this factor in the formation of liver fibrosis.